Loading...

/News/RNS

Director/PDMR Shareholding

RNS Announcement

RNS Number : 4890E

GlaxoSmithKline PLC

18 July 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr P J T Vallance

b)

Position/status

President, Pharmaceuticals R&D

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

b)

Nature of the transaction

Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016, on Ordinary Shares held in the Company's Deferred Investment Award Programme.

c)

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.4900	454.329

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2016-07-14

f)

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHXVLFFQDFEBBF

RNS metadata

Title: Director/PDMR Shareholding
Time: 15:53:36
Date: 18 Jul 2016
Category: Director/PDMR dealings
ID: 4890E